Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02065154
What this trial is testing

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome+3 more
University of Alabama at Birmingham 39
Post-approval studies (Phase 4)UnknownNCT02905942
What this trial is testing

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Lymphoma
Peking University 96
Early research (Phase 1)Study completedNCT00003243
What this trial is testing

Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Early research (Phase 1)Looking for participantsNCT03533816
What this trial is testing

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
University of Kansas Medical Center 38
Early research (Phase 1)Study completedNCT01497184
What this trial is testing

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 95
Early research (Phase 1)Ended earlyNCT05065047
What this trial is testing

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05317416
What this trial is testing

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

Who this might be right for
Multiple Myeloma
Pfizer 854
Testing effectiveness (Phase 2)Study completedNCT05338047
What this trial is testing

Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

Who this might be right for
Myeloma MultipleLymphoma
Hospital Universitario Dr. Jose E. Gonzalez 30
Testing effectiveness (Phase 2)Looking for participantsNCT04746209
What this trial is testing

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-Cell ALL, Childhood
Medical College of Wisconsin 25
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00134017
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142
Testing effectiveness (Phase 2)Study completedNCT02362997
What this trial is testing

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL

Who this might be right for
Hodgkin LymphomaDiffuse Large B Cell LymphomaPeripheral T-Cell Lymphoma
Dana-Farber Cancer Institute 82
Testing effectiveness (Phase 2)Study completedNCT00795886
What this trial is testing

Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
University of Utah 63
Not applicableStudy completedNCT00507260
What this trial is testing

Nutritional Assessment Intervention to Improve Cancer-Related Fatigue

Who this might be right for
LeukemiaLymphomaFatigue
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)WithdrawnNCT05820763
What this trial is testing

Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant

Who this might be right for
Multiple MyelomaMyeloma-Associated Amyloidosis
Washington University School of Medicine
Not applicableStudy completedNCT02182986
What this trial is testing

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Who this might be right for
Heart TransplantSmall Intestine TransplantKidney Transplant+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 944
Not applicableNot Yet RecruitingNCT07746232
What this trial is testing

Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

Who this might be right for
Multiple Myeloma (MM)
Fondazione EMN Italy Onlus 92
Next Page